BioSpace News Archive

Business

Dong-A ST and Beactica Expand Their Research and Licence Agreement to Develop New Cancer Treatments

Dong-A ST Co., Ltd., the Korean pharmaceutical company, and Beactica AB, the Swedish drug discovery company, announced an expansion of their research and licensing agreement.

March 12, 2019
·
3 min read
Job Trends

Underweight patients at greatest risk of complications following total shoulder arthroplasty

While studies often identify obesity as a potential risk factor for complications following total shoulder arthroplasty, few have looked at outcomes for patients who are underweight.

March 12, 2019
·
3 min read
Policy

ERS Genomics Provides Comment on Issuance of University of California CRISPR/Cas9 Patent Including Uses of CRISPR ‘in a cell’

U.S. Patent No. 10,227,611 issued to Dr. Emmanuelle Charpentier, University of California and University of Vienna

March 12, 2019
·
2 min read
Policy

Clever Leaves First Colombian Cannabis Company Authorized to Grow Commercially

Clever Leaves, a leading vertically-integrated Colombian licensed producer of pharmaceutical-grade medical cannabis serving the global market has become the first cannabis company authorized by Colombian regulators to commercially cultivate cannabis for medical purposes.

March 12, 2019
·
4 min read
Genetown

Concert Pharmaceuticals to Present at Upcoming Oppenheimer Healthcare Conference

Concert Pharmaceuticals, Inc. announced that it will present a corporate overview at the Oppenheimer 29th Annual Healthcare Conference on March 19, 2019 at 1:00 p.m. ET in New York, NY.

March 12, 2019
·
1 min read
Deals

Verastem Oncology to Present at Upcoming Investor Conferences

Verastem, Inc., focused on developing and commercializing medicines seeking to improve the survival and quality of life of cancer patients, announced that the Company will present at the following upcoming investor conferences

March 12, 2019
·
1 min read
Business

Synlogic Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update

Clinical trial readouts expected in mid-2019 from two Synthetic Biotic™ medicines and first IND application expected from Synlogic’s immuno-oncology platform in second half of 2019

March 12, 2019
·
10 min read
Drug Development

Rocket Pharmaceuticals Announces First Patient Dosed in Phase 1 Clinical Trial of RP-L102 in the U.S.

Trial to Use “Process B” RP-L102, Which Incorporates Higher Cell Doses, Transduction Enhancers, and Commercial-grade Vector Manufacturing and Cell Processing

March 12, 2019
·
8 min read
Policy

Compugen Announces Issuance of Two U.S. Composition of Matter Patents for COM701, Its Lead Immuno-Oncology Product Candidate

Composition of matter patents expand intellectual property position beyond previously granted therapeutic use

March 12, 2019
·
5 min read
Biotech Bay

ForteBio Introduces New Product for High-Throughput Glycan Screening

The Sialic Acid kit, which is designed for use on the industry leading Octet® instruments, presents a revolutionary opportunity to screen for optimal sialylation faster, earlier in development, and with more samples than allowed by conventional techniques.

March 12, 2019
·
2 min read